Why Bristol-Myers Applies To Federal Class Actions

By William Delgado and Amelia Sargent ( March 30, 2018, 11:29 AM EDT) -- On June 19, 2017, the U.S. Supreme Court issued a ruling with major implications for the ability of plaintiffs to band together to sue foreign corporations who are not "at home" in the state in which the lawsuit is brought. In Bristol-Myers Squibb Co. v. Superior Court of California, 137 S. Ct. 1773 (2017), a group of plaintiffs — some California residents, some not — brought a mass tort action against the pharmaceutical manufacturer Bristol-Myers Squibb (BMS) for injuries allegedly caused by the drug Plavix. Lacking general personal jurisdiction over BMS, which is incorporated in Delaware and headquartered in New York, the plaintiffs argued that the California Superior Court could nevertheless exercise specific personal jurisdiction because of BMS's wide-ranging business contacts within the state of California....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!